Dr Lisa Byers Controlled Drug Accountable Officer (CDAO, Primary Care NI)
Aim
To outline the new process for GPs when reporting controlled drug-related issues and concerns that occur in the primary care general medical services (GMS) setting.
Learning outcomes
Having attended this webinar, you will be able to:
Describe the statutory responsibility of the Controlled Drugs Accountable Officer (CDAO) for primary care NI, in relation to the GMS setting and with regard to the CD Regulations NI 2009
Identify what constitutes a CD incident or concern
Understand the legal requirement to notify the CDAO of any concerns or adverse incidents involving CDs as part of a risk management process
Demonstrate how to use the new CD reporting tool
Outline how CD-related adverse incidents and concerns are managed once reported.
To provide an overview of the pharmacological management of chronic pain.
Learning outcomes
Having attended this webinar, you will be able to:
Understand the latest NICE guidance for treating chronic pain, encompassing primary and secondary chronic pain
Outline the pharmacological management of chronic pain, including nociceptive, neuropathic, and nociplastic pain
Communicate the risks associated with dependence-forming medicines with patients
Undertake a medication review in consultation with the patient and deprescribe or reduce inappropriate medicines through a shared decision-making process.
Medicines Management of Eating, Drinking and Swallowing Difficulties
Ms Clare Stevenson Speech and Language Therapist and Dysphagia Coordinator SEHSCT
Aim
To provide an overview of the best practice in recognising and responding to dysphagia in adult patients and how dysphagia relates to medication options.
Learning outcomes
Having attended this webinar, you will be able to:
Identify of eating, drinking and swallowing difficulties in adult patients
Recognise the needs of patients with swallowing difficulties and when Speech and Language therapy should be involved
Outline IDDSI descriptors and how thickeners may be used within different IDDSI levels
Understand the stepwise approach to medication selection for patients with dysphagia
Signpost to resources to assist with medication selection
Utilise learning from local serious adverse incidents to reduce patient harm
Dr Lisa Byers Controlled Drug Accountable Officer (CDAO, Primary Care NI)
Ms Joy Watson Addictions Consultant, BHSCT
Mr Canice Ward Head of Medicines Regulatory Group, Department of Health
Dr Carolyn Adgey Consultant Gastroenterologist, BHSCT
Aim
To provide a discussion forum to explore the potential misuse of OTC opioid products. Specifically, to recognise the signs and symptoms of their misuse, discuss and explore strategies to manage the supply of these medicines in the community pharmacy setting and provide support to patients who have developed problems with these products.
Learning outcomes
Having completed this webinar, you will be able to:
Define the terms misuse and dependence
Recognise signs of opioid misuse and dependence
Consider strategies to help prevent/reduce the abuse of opioid products in a community pharmacy setting
Discuss the risks of potential misuse/dependence with patients
Share your knowledge with your pharmacy team to ensure safe and effective supply of OTC opioid products.